Abstract
Citrate is commonly used as an anticoagulant in hemodialysis for chronic renal failure (CRF) and for the regulation of the immune dysfunction in CRF patients. The objective of this study was to investigate the effect of citrate on the balance of T helper 17 (Th17) and regulatory T (Treg) cells in CRF. The levels of blood urea nitrogen (BUN) and serum creatinine (Scr) were significantly increased in the CRF model group compared to the control group, and were decreased in the citrate-treated groups. Citrate treatment inhibited the viability of Th17 cells while elevating the viability of Treg cells in CRF rats. Moreover, Th17-related cytokines significantly decreased while the Treg-related cytokines significantly increased with citrate treatment. Moreover, citrate had a negative influence on the deviation of Th17/Treg cells in CRF rats. Therefore, our study suggests that citrate had an anti-inflammatory effect on CRF through the modulation of the Th17/Treg balance.
Similar content being viewed by others
Abbreviations
- CRF:
-
Chronic renal failure
- Th:
-
T helper
- Treg:
-
Regulatory T cell
- RA:
-
Rheumatoid arthritis
- SD:
-
Sprague-Dawley
- BUN:
-
Blood urea nitrogen
- Scr:
-
Serum creatinine
- PBS:
-
Phosphate-buffered solution
- RoR:
-
Transcription factor retinoic acid receptor-related orphan receptor
- Foxp3:
-
Forkhead box P3
References
Zhang, L., F. Wang, L. Wang, W. Wang, B. Liu, J. Liu, M. Chen, Q. He, Y. Liao, and X. Yu. 2012. Prevalence of chronic kidney disease in China: a cross-sectional survey. The Lancet 379: 815–822.
Vaziri, N.D., M. Dicus, N.D. Ho, L. Boroujerdi-Rad, and R.K. Sindhu. 2003. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney International 63: 179–185.
Litjens, N.H., M. Huisman, M. van den Dorpel, and M.G. Betjes. 2008. Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients. Journal of the American Society of Nephrology 19: 1483–1490.
Chung, B.H., K.W. Kim, I.O. Sun, S.R. Choi, H.S. Park, E.J. Jeon, B.M. Kim, B.S. Choi, C.W. Park, Y.S. Kim, et al. 2012. Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients. Immunology Letters 141: 181–189.
Lisowska, K.A., A. Debska-Slizien, A. Jasiulewicz, E. Bryl, and J.M. Witkowski. 2014. Influence of hemodialysis on circulating CD4(low)CD25 (high) regulatory T cells in end-stage renal disease patients. Inflammation Research 63: 99–103.
Noack, M., and P. Miossec. 2014. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmunity Reviews 13: 668–677.
Shen, X., J. Du, W. Guan, and Y. Zhao. 2014. The balance of intestinal Foxp3+ regulatory T cells and Th17 cells and its biological significance. Expert Review of Clinical Immunology 10: 353–362.
Kurebayashi, Y., S. Nagai, A. Ikejiri, and S. Koyasu. 2013. Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells. Genes to Cells 18: 247–265.
Guzman-Flores, J.M., and D.P. Portales-Perez. 2013. [Mechanisms of suppression of regulatory T-cells (Treg)]. Gaceta Médica de México 149: 630–638.
Wang, W., S. Shao, Z. Jiao, M. Guo, H. Xu, and S. Wang. 2012. The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis. Rheumatology International 32: 887–893.
Fletcher, J.M., R. Lonergan, L. Costelloe, K. Kinsella, B. Moran, C. O’Farrelly, N. Tubridy, and K.H. Mills. 2009. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. Journal of Immunology 183: 7602–7610.
Zou Y, Dai SX, Chi HG, Li T, He ZW, Wang J, Ye CG, Huang GL, Zhao B, Li WY, et al. 2014. Baicalin attenuates TNBS-induced colitis in rats by modulating the Th17/Treg paradigm. Archives of Pharmacal Research. doi:10.1007/s12272-014-0486-2
Maddur, M.S., P. Miossec, S.V. Kaveri, and J. Bayry. 2012. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. American Journal of Pathology 181: 8–18.
Dickens, F. 1941. The citric acid content of animal tissues, with reference to its occurrence in bone and tumour. Biochemistry Journal 35: 1011–1023.
Kim, S., J.Y. Yang, E.S. Jung, J. Lee, N.J. Heo, J.W. Lee, K.Y. Na, and J.S. Han. 2014. Effects of sodium citrate on salt sensitivity and kidney injury in chronic renal failure. Journal of Korean Medical Science 29: 1658–1664.
Manotham, K., S. Eiam-Ong, P. Wannakrairot, K. Praditpornsilpa, S. Chusil, and K. Tungsanga. 2006. Citrate attenuates tubulointerstitial fibrosis in 5/6 nephrectomized rats by decreasing transforming growth factor-beta1. Journal of the Medical Association of Thialand 89(Suppl 2): S168–177.
Oudemans-van Straaten, H.M. 2010. Citrate anticoagulation for continuous renal replacement therapy in the critically ill. Blood Purification 29: 191–196.
Wang, Ting, and Baosong Gui. 2007. Safety evaluation and changes of lymphocyte subsets in using hemodialysate containing citrate and bicarbonate. Chinese Journal of Blood Purification 6: 199–203.
Xu, G., and Y. Gong. 2013. Deregulation from CD4+ memory T cells to regulatory cells in patients with chronic renal failure: a pilot study. Journal of Clinical Laboratory Analysis 27: 423–426.
Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133: 775–787.
Zhou, L., M.M. Chong, and D.R. Littman. 2009. Plasticity of CD4+ T cell lineage differentiation. Immunity 30: 646–655.
Zhang, J., G. Hua, X. Zhang, R. Tong, X. Du, and Z. Li. 2010. Regulatory T cells/T-helper cell 17 functional imbalance in uraemic patients on maintenance haemodialysis: a pivotal link between microinflammation and adverse cardiovascular events. Nephrology (Carlton, Vic.) 15: 33–41.
Kim, K.W., B.H. Chung, B.M. Kim, M.L. Cho, and C.W. Yang. 2015. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients. Immunology 144: 68–78.
Robinson, M.R., V.A. Leitao, G.E. Haleblian, C.D. Scales Jr., A. Chandrashekar, S.A. Pierre, and G.M. Preminger. 2009. Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation. Journal of Urology 181: 1145–1150.
Oudemans-van Straaten, H.M., R.J. Bosman, M. Koopmans, P.H. van der Voort, J.P. Wester, J.I. van der Spoel, L.M. Dijksman, and D.F. Zandstra. 2009. Citrate anticoagulation for continuous venovenous hemofiltration. Critical Care Medicine 37: 545–552.
Eto, N., Y. Miyata, H. Ohno, and T. Yamashita. 2005. Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure. Nephrology, Dialysis, Transplantation 20: 1378–1384.
Peng, M., P. Cai, H. Ma, H. Meng, Y. Xu, X. Zhang, and G. Si. 2014. Chinese herbal medicine Shenqi Detoxification Granule inhibits fibrosis in adenine induced chronic renal failure rats. African Journal of Traditional, Complementary, and Alternative Medicines 11: 194–204.
Waring, W.S., and A. Moonie. 2011. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury. Clinical Toxicology (Philadelphia, Pa.) 49: 720–728.
Emans, M.E., B. Braam, A. Diepenbroek, K. van der Putten, M.J. Cramer, J.P. Wielders, D.W. Swinkels, P.A. Doevendans, and C.A. Gaillard. 2012. Neutrophil gelatinase-associated lipocalin (NGAL) in chronic cardiorenal failure is correlated with endogenous erythropoietin levels and decreases in response to low-dose erythropoietin treatment. Kidney and Blood Pressure Research 36: 344–354.
Hosohata, K., H. Ando, Y. Fujiwara, and A. Fujimura. 2011. Vanin-1: a potential biomarker for nephrotoxicant-induced renal injury. Toxicology 290: 82–88.
Radeke, H.H., T. Tschernig, A. Karulin, G. Schumm, S.N. Emancipator, K. Resch, and M. Tary-Lehmann. 2002. CD4+ T cells recognizing specific antigen deposited in glomeruli cause glomerulonephritis-like kidney injury. Clinical Immunology 104: 161–173.
Noma, T. 2010. Helper T cell paradigm: Th17 and regulatory T cells involved in autoimmune inflammatory disorders, pathogen defense and allergic diseases. Nihon Rinshō Men'eki Gakkai Kaishi 33: 262–271.
Mahajan, D., Y. Wang, X. Qin, G. Zheng, Y.M. Wang, S.I. Alexander, and D.C. Harris. 2006. CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease. Journal of the American Society of Nephrology 17: 2731–2741.
Bettelli, E., M. Oukka, and V.K. Kuchroo. 2007. T(H)-17 cells in the circle of immunity and autoimmunity. Nature Immunology 8: 345–350.
Rodrigues-Diez, R., S. Rayego-Mateos, M. Orejudo, L.S. Aroeira, R. Selgas, A. Ortiz, J. Egido, and M. Ruiz-Ortega. 2015. TGF-beta blockade increases renal inflammation caused by the C-terminal module of the CCN2. Mediators of Inflammation 2015: 506041.
Acknowledgments
The study was supported by the National Natural Science Foundation of China (Program NO. 81200554), Natural Science Basic Reasearch Plan in Shaanxi Province of China (Program NO. 2010JQ4025), and International Cooperation Project of Xi’an Jiaotong University.
Conflict of Interest
All the authors have no conflict of interest to declare. No competing financial interests exist.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ou, Y., Li, S., Zhu, X. et al. Citrate Attenuates Adenine-Induced Chronic Renal Failure in Rats by Modulating the Th17/Treg Cell Balance. Inflammation 39, 79–86 (2016). https://doi.org/10.1007/s10753-015-0225-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-015-0225-y